Dr. Ashlee Strubberg details how Integrated DNA Technologies’ (IDT) PrimeTime Pathogen Research Panels can accelerate PCR workflows. By selecting only targets of interest, researchers are able to reduce time-consuming workflows and reduce costs. Targets are highly customizable with a fluorophore of interest. Hundreds of targets span 11 different disease categories, from antimicrobial resistance to sexual health to respiratory pathogens. Webinar learning objectives

Commercial Product Manager, PCR
Integrated DNA Technologies
Dr. Ashlee Strubberg has nearly a decade of experience as a subject matter expert in PCR-based applications at IDT. Prior to joining IDT, she earned her B.S. in Biochemistry and Ph.D. in Biomedical Sciences from the University of Missouri and completed postdoctoral training in Gastroenterology at Washington University in St. Louis. Her academic research centered around intestinal stem cell physiology and its role in gastrointestinal cancers and genetic diseases, including cystic fibrosis.